STOCK MARKET BSE NSE

Switzerland approves Pfizer-BioNTech COVID-19 vaccine

The country's health agency Swissmedic said in a written statement Saturday that the vaccine had been approved for the small Alpine country after a careful examination by expert teams.

Published: 19th December 2020 06:13 PM  |   Last Updated: 19th December 2020 06:13 PM   |  A+A-

An expert committee convened by the US Food and Drug Administration on December 10, 2020, voted heavily in favor of recommending the Pfizer-BioNTech Covid-19 vaccine for emergency use approval. | AFP

Pfizer-Biontech vaccine(Photo | AFP)

By PTI

BERLIN: Switzerland has approved the COVID-19 vaccine from Pfizer and German pharmaceutical company BioNTech.

The country's health agency Swissmedic said in a written statement Saturday that the vaccine had been approved for the small Alpine country after a careful examination by expert teams.

The agency did not say when vaccinations in Switzerland would begin.

The approval comes shortly after Britain, Canada, the United States and other countries allowed the use of the vaccine in their respective countries.

The director of Swissmedic said “Thanks to the rolling process and our flexible teams we could quickly decide and fully accommodate the three most important requirements security, efficacy and quality.”

Raimund Bruhin added that, “The safety of the patients is a required condition especially regarding the approval of vaccines.”



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp